Zdrowie i gospodarka · 28/03/2006

FDA Announces Final Guidance for Clinical Trial Data Monitoring Committees

The Food and Drug Administration (FDA) has released a final guidance document to help clinical trial sponsors determine when to establish a data monitoring committee and how to operate one, building on a previous draft from 2001.